Industries > Pharma > Pharmaceutical Contract Manufacturing Market Report 2022-2032
Pharmaceutical Contract Manufacturing Market Report 2022-2032
Forecasts by Services (Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services), Drug Development Services, Biologics Contract Manufacturing Services (Biologics API Manufacturing Services, Biologics FDF Manufacturing Services)), by End-user (Big Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
Investments in Advanced Manufacturing Technologies by CDMOs
In the last few decades, CDMOs have steadily established expertise and facilities to manufacture drugs at full scale. They have incorporated various methods for manufacturing drugs at the lowest possible operational cost. An increasing number of contract manufacturers are investing in continuous manufacturing methods as well to conventions in batch processing methods. Due to the availability of advanced technology, the major companies are planning to provide CDMO services for companies seeking technology development, processing and production services.
Also, to spur growth, the CDMO industry is taking on capital projects and investing in new technologies to share risks with manufacturers, in response to the high capacity utilization rates. As indicated by the higher utilization rates, they are also hiring more personnel. The manufacturing of highly potent active pharmaceutical ingredients (HPAPIs) requires complex manufacturing processes; advanced synthesis and formulation expertise; and special protective equipment, manufacturing sites, production processes, and management systems. Such strategic expansions, investments, and acquisitions by CDMOs have helped them increase their service offerings and expand their customer base while providing significant cross-selling opportunities.
Services Analysis
Drug development services, pharmaceutical manufacturing services, and biologic manufacturing services are all subcategories of the pharmaceutical contract manufacturing sector. Pharmaceutical manufacturers’ limited financial resources, capacity constraints, the need to shorten time-to-market, complex manufacturing requirements, large investments in setting up manufacturing facilities, and the expanding pipeline have all contributed to this market segment’s dominance of pharmaceutical contract manufacturing.
Large portions of this market can be attributed to the fact that pharmaceutical manufacturers have limited resources and therefore must turn to Pharmaceutical Contract manufacturing in order to cut down on time-to-market and meet the increasingly complex manufacturing needs that have resulted from the high costs of setting up manufacturing facilities as well as the ever-expanding pipeline. On the other hand, the biologics manufacturing segment is expected to grow at the highest rate owing to the growing demand for vaccines and biosimilars.
What are the Growth Drivers for Pharmaceutical Contract Manufacturing Market?
• Patent expiry and increasing demand for generic drugs
• Increasing investments in pharmaceutical R&D
• Investments In advanced manufacturing technologies by CDMOs
What are the Market Opportunities?
• Increasing demand for biological therapies
• Growth in the nuclear medicine sector
• Growing demand for cell and gene therapies
Discover how to stay ahead
Our 440+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Pharmaceutical Contract Manufacturing Market. See how to exploit the opportunities.
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and sub-markets
By Services
• Pharmaceutical Manufacturing Services
– Pharmaceutical API Manufacturing Services
– Pharmaceutical FDF Manufacturing Services
• Drug Development Services
• Biologics contract manufacturing services
– Biologics API manufacturing services
– Biologics FDF manufacturing services
By End User
• Big Pharmaceutical Companies
• Small & Medium-Sized Pharmaceutical Companies
• Generic Pharmaceutical Companies
• Other End Users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 14 leading national markets:
By Region
North America
• U.S.
• Canada
Europe
• Germany
• France
• UK
• Italy
• Spain
• Switzerland
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• South Korea
• Rest of Asia Pacific
LAMEA
• Brazil
• Mexico
• Rest of LAMEA
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for Pharmaceutical Contract Manufacturing Market will surpass $126 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the major companies involved in the Pharmaceutical Contract Manufacturing market. Some of the companies profiled in this report include AbbVie Inc., Abnova Corporation, Boehringer Ingelheim International GmbH, Catalent, Inc., Evonik Industries AG, Fujifilm Corporation, ICON PLC, Lonza Group Ltd., Piramal Pharma Solutions, Recipharm AB, Samsung Biologics, Siegfried Holding AG, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, and WuXiAppTec among other prominent players.
How the Pharmaceutical Contract Manufacturing Market report helps you
In summary, our 440+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Pharmaceutical Contract Manufacturing Market, with forecasts for 3 services, and 4 end-users each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 4 regional and 14 key national markets– See forecasts for the Pharmaceutical Contract Manufacturing market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the companies involved in the Pharmaceutical Contract Manufacturing Market. Some of the company’s profiled in this report include AbbVie Inc., Abnova Corporation, Boehringer Ingelheim International GmbH, Catalent, Inc., Evonik Industries AG, Fujifilm Corporation, ICON PLC, Lonza Group Ltd., Piramal Pharma Solutions, Recipharm AB, Samsung Biologics, Siegfried Holding AG, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, and WuXiAppTec among other prominent players.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pharmaceutical Contract Manufacturing Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Pharmaceutical Contract Manufacturing Market Report 2022-2032: Forecasts by Services (Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services), Drug Development Services, Biologics Contract Manufacturing Services (Biologics API Manufacturing Services, Biologics FDF Manufacturing Services), by End-user (Big Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1.1 Introduction to Global Pharmaceutical Contract Manufacturing Market
1.2 Global Pharmaceutical Contract Manufacturing Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Qualitative Analysis of the Global Pharmaceutical Contract Manufacturing Market
3.1 Market Dynamics
3.1.1 Drivers
3.1.1.1 Patent expiry and increasing demand for generic drugs
3.1.1.2 Increasing investments in pharmaceutical R&D
3.1.1.3 Investments in advanced manufacturing technologies by CDMOs
3.1.2 Restraints
3.1.2.1 Introduction of serialization
3.1.3 OPPORTUNITIES
3.1.3.1 Increasing demand for biological therapies
3.1.3.2 Growth in the nuclear medicine sector
3.1.3.3 Growing demand for cell and gene therapies
3.2 SWOT Analysis
3.3 PEST Analysis
3.3.1 Political
3.3.2 Economic
3.3.3 Sociocultural
3.3.4 Technological
3.4 Porter’s Five Forces Analysis
3.4.1 Moderate Bargaining Power of Supplier
3.4.2 High Bargaining Power of Buyer
3.4.3 Low Threat of New Entrants
3.4.4 Low Threat of Substitutes
3.4.5 High Intensity of Competitive Rivalry
3.5 COVID-19 Impact Analysis
3.5.1 V-Shaped Recovery
3.5.2 U-Shaped Recovery
3.5.3 L-Shaped Recovery
3.5.4 W-Shaped Recovery
4 Global Pharmaceutical Contract Manufacturing Market, by Services, 2022-2032
4.1 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, 2022-2032
4.2 PHARMACEUTICAL MANUFACTURING SERVICES
4.2.1 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.3 PHARMACEUTICAL API MANUFACTURING SERVICES
4.2.3.1 Need to cut costs and ensure focus on core areas leads companies to outsource API manufacturing
4.2.3.2 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.4 PHARMACEUTICAL FDF MANUFACTURING SERVICES
4.2.4.1 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.4.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.4.3 Parenteral/Injectable manufacturing services
4.2.4.3.1 Need for high levels of expertise and growing drug development activities are driving the demand for contract manufacturing
4.2.4.3.2 Global Pharmaceutical Contract Manufacturing Market for Parenteral/injectable manufacturing services: Market Forecast, 2022-2032
4.2.4.4 Tablet manufacturing services
4.2.4.4.1 Shifting manufacturing requirements and the need to streamline production processes are driving market growth
4.2.4.4.2 Global Pharmaceutical Contract Manufacturing Market for Tablet manufacturing services: Market Forecast, 2022-2032
4.2.4.5 Capsule manufacturing services
4.2.4.5.1 Growth in demand for capsule formulations has ensured growth opportunities for service providers
4.2.4.5.2 Global Pharmaceutical Contract Manufacturing Market for Capsule manufacturing services: Market Forecast, 2022-2032
4.2.4.6 Oral liquid manufacturing services
4.2.4.6.1 Complexities involved in oral liquid manufacturing have prompted companies to opt for outsourcing
4.2.4.6.2 Global Pharmaceutical Contract Manufacturing Market for Oral liquid manufacturing services: Market Forecast, 2022-2032
4.2.4.7 Semi-solid manufacturing services
4.2.4.7.1 Demand for specific manufacturing facilities to boost the outsourcing of semi –solids
4.2.4.7.2 Global Pharmaceutical Contract Manufacturing Market for Semi-solid manufacturing services: Market Forecast, 2022-2032
4.2.4.8 Other Formulation manufacturing services
4.2.4.8.1 Demand for specific manufacturing facilities to boost the outsourcing of semi –solids
4.2.4.8.2 Global Pharmaceutical Contract Manufacturing Market for Other Formulation manufacturing services: Market Forecast, 2022-2032
4.3 Drug Development Services
4.3.1 Drug Substance Complexity And High Costs Have Supported The Outsourcing Of Drug Development
4.3.2 Global Pharmaceutical Contract Manufacturing Market for Drug Development Services: Market Forecast, 2022-2032
4.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services: Recovery Scenarios (V, U, W, L)
4.4 Biologics Contract Manufacturing Services
4.4.1 Global Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services: Market Forecast, 2022-2032
4.4.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services: Recovery Scenarios (V, U, W, L)
4.4.1 Biologics API Manufacturing Services
4.4.1.1 This market is still in the nascent phase
4.4.1.2 Global Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services by Region: Market Forecast, 2022-2032
4.4.1.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.4.2 Biologics FDF Manufacture Service
4.4.2.1 Increasing R&D costs and process complexity have prompted the shift toward contract manufacturing
4.4.2.2 Global Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service by Region: Market Forecast, 2022-2032
4.4.2.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service: Recovery Scenarios (V, U, W, L)
5 Global Pharmaceutical Contract Manufacturing Market, by End User, 2022-2032
5.1 Global Pharmaceutical Contract Manufacturing Market Forecast by End User, 2022-2032
5.2 Big Pharmaceutical Companies
5.2.1 Global Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.2.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Big pharmaceutical companies: Recovery Scenarios (V, U, W, L)
5.3 Small & Medium-Sized Pharmaceutical Companies
5.3.1 Growing Development Of Biologic Drugs And High Pricing Pressure To Boost Market Growth
5.3.2 Global Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Small & Medium-Sized Pharmaceutical Companies: Recovery Scenarios (V, U, W, L)
5.4 Generic Pharmaceutical Companies
5.4.1 Growing Demand For Generics To Support Market Growth
5.4.2 Global Pharmaceutical Contract Manufacturing Market for Generic Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.4.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Generic Pharmaceutical Companies: Recovery Scenarios (V, U, W, L)
5.5 Other End Users
5.5.1 Global Pharmaceutical Contract Manufacturing Market for Other End Users by Region: Market Forecast, 2022-2032
5.5.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Other End Users: Recovery Scenarios (V, U, W, L)
6 North America Pharmaceutical Contract Manufacturing Market, 2022-2032
6.1.1 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
6.2 North America Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.2.1 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.2.2 North America Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.3 North America Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.4 North America Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
6.5 US
6.5.1 The US dominates the North American Pharmaceutical Contract manufacturing market
6.5.2 Increasing funding from Federal Government
6.5.3 U.S. Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.5.4 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.5.5 US Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.5.6 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.5.7 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
6.6 Canada
6.6.1 Rising incidence of chronic lifestyle diseases is expected to boost the market growth
6.6.2 Government initiatives to promote pharmaceutical contract manufacturing in various indications to drive market growth in Canada
6.6.3 Canada Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.6.4 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.6.5 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.6.6 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.6.7 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7 Europe Pharmaceutical Contract Manufacturing Market, 2022-2032
7.1.1 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.2 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.2.1 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.2.2 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.3 Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.4 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
7.5 Germany
7.5.1 High healthcare expenditure by the country
7.5.2 Increased pharmaceutical production to support market demand
7.5.3 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.5.4 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.5.5 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.5.6 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.5.7 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.6 UK
7.6.1 Growth In The Generics Market And The Rising Cost Of Manufacturing Parenteral Formulations Are Driving Market Growth
7.6.2 Increasing R&D research will boost the market
7.6.3 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.6.4 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.6.5 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.6.6 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.6.7 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.7 Switzerland
7.7.1 Large volume of pharmaceutical production and growing scope for generics to provide growth opportunities
7.7.2 Switzerland boasts a strong research oriented pharma industry, a key factor supporting market growth.
7.7.3 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.7.4 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.7.5 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.7.6 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.7.7 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.8 France
7.8.1 Presence of leading pharmaceutical companies to support market growth in France
7.8.2 Availability of reimbursement
7.8.3 France Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.8.4 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.8.5 France Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.8.6 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.8.7 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.9 Italy
7.9.1 Increasing focus on clinical research and the growing popularity of branded drugs are driving the demand for contract development and manufacturing
7.9.2 Economic slowdown of Italian healthcare industry
7.9.3 Italy Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.9.4 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.9.5 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.9.6 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.9.7 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.10 Spain
7.10.1 Increase in biologics production to support market growth
7.10.2 Advancement in the production and research of innovative drugs
7.10.3 Spain Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.10.4 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.10.5 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.10.6 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.10.7 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.11 Rest of Europe
7.11.1 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.11.2 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.11.3 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.11.4 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.11.5 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8 Asia-Pacific Pharmaceutical Contract Manufacturing Market, 2022-2032
8.1.1 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.2.1 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.2.2 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
8.5 Japan
8.5.1 Growing generics demand to drive the demand for contract manufacturing of drugs
8.5.2 Government initiatives to increase the use of generic drugs
8.5.3 Japan Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.5.4 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.5.5 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.5.6 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.5.7 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.6 China
8.6.1 Favourable government regulations are fuelling market growth in China
8.6.2 Strong focus of key market players to expand their business In China
8.6.3 China Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.6.4 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.6.5 China Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.6.6 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.6.7 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.7 India
8.7.1 Low manufacturing costs is attracting outsourcing
8.7.2 Presence of skilled workforce
8.7.3 India Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.7.4 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.7.5 India Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.7.6 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.7.7 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.8 South Korea
8.8.1 Government investments are a key contributor to market growth in South Korea
8.8.2 Increase in initiative of government research funding
8.8.3 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.8.4 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.8.5 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.8.6 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.8.7 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.9 Rest of APAC
8.9.1 Singapore and Malaysia are major markets in Rest of APAC
8.9.2 Taiwan and Malaysia are some of the emerging countries
8.9.3 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.9.4 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.9.5 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.9.6 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.9.7 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9 Latin America, Middle East & Africa (LAMEA) Pharmaceutical Contract Manufacturing Market, 2022-2032
9.1.1 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.2 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.2.1 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.2.2 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.3 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.4 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
9.5 Brazil
9.5.1 Increasing focus of BNCs on the pharmaceutical and healthcare sectors
9.5.2 Production-development partnerships have been implemented
9.5.3 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.5.4 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.5.5 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.5.6 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.5.7 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.6 Mexico
9.6.1 One of the largest exporters of pharmaceutical products in Latin America
9.6.2 Increased focus among key players to expand their business in Mexico
9.6.3 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.6.4 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.6.5 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.6.6 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.6.7 Mexico
9.6.8 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.7 Saudi Arabia
9.7.1 Largest pharmaceutical market in the Middle East
9.7.2 High-profile agreements and collaborations in the country
9.7.3 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.7.4 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.7.5 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.7.6 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.7.7 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.8 Rest of LAMEA
9.8.1 Government initiatives to tackle the growing burden of pharmaceutical costs
9.8.2 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.8.3 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.8.4 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.8.5 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.8.6 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
10 Company Profiles
10.1 Market Share Analysis
10.2 LONZA GROUP
10.2.1 Company overview
10.2.2 Company Snapshot
10.2.3 Service Portfolio
10.2.4 Financial Analysis
10.2.4.1 Net Revenue, 2016-2020
10.2.4.2 Segmental Revenue Shares, 2020
10.2.4.3 Regional Revenue Shares, 2020
10.2.5 Recent Developments, 2017-2020
10.3 THERMO FISHER SCIENTIFIC INC.
10.3.1 Company overview
10.3.2 Company Snapshot
10.3.3 Service Portfolio
10.3.4 Financial Analysis Net Revenue, 2016-2020
10.3.4.1 Segmental Revenue Shares, 2020
10.3.4.2 Regional Revenue Shares, 2020
10.3.5 Recent Developments, 2018-2020
10.4 CATALENT
10.4.1 Company Overview
10.4.2 Company Snapshot
10.4.3 Service Portfolio
10.4.4 Financial Analysis
10.4.4.1 Net Revenue, 2016-2020
10.4.4.2 Segmental Revenue Shares, 2021
10.4.4.3 Regional Revenue Shares, 2021
10.4.5 Recent Developments, 2018-2020
10.5 RECIPHARM AB
10.5.1 Company Overview
10.5.2 Company Snapshot
10.5.3 Service Portfolio
10.5.4 Financial Analysis
10.5.4.1 Net Revenue, 2016-2020
10.5.4.2 Segmental Revenue Shares, 2020
10.5.5 Recent Developments, 2017-2020
10.6 ABBVIE
10.6.1 Company Overview
10.6.2 Company Snapshot
10.6.3 Service Portfolio
10.6.4 Financial Analysis
10.6.4.1 Net Revenue, 2016-2020
10.6.4.2 Segmental Revenue Shares, 2020
10.6.4.3 Regional Revenue Shares, 2020
10.6.5 Recent Developments, 2020
10.7 SIEGFRIED HOLDING AG
10.7.1 Company Overview
10.7.2 Company Snapshot
10.7.3 Service Portfolio
10.7.4 Financial Analysis
10.7.4.1 Net Revenue, 2016-2020
10.7.5 Recent Developments, 2019
10.8 EVONIK INDUSTRIES
10.8.1 Company Overview
10.8.2 Company Snapshot
10.8.3 Service Portfolio
10.8.4 Financial Analysis
10.8.4.1 Net Revenue, 2016-2020
10.8.4.2 Segmental Revenue Shares, 2020
10.8.4.3 Regional Revenue Shares, 2019
10.8.5 Recent Developments, 2020
10.9 BOEHRINGER INGELHEIM
10.9.1 Company Overview
10.9.2 Company Snapshot
10.9.3 Service Portfolio
10.9.4 Financial Analysis
10.9.4.1 Net Revenue, 2016-2020
10.9.4.2 Segmental Revenue Shares, 2020
10.9.4.3 Regional Revenue Shares, 2020
10.9.5 Recent Developments, 2017-2019
10.10 PIRAMAL PHARMA SOLUTIONS
10.10.1 Company Overview
10.10.2 Company Snapshot
10.10.3 Service Portfolio
10.10.4 Financial Analysis
10.10.4.1 Net Revenue, 2017-2021
10.10.4.2 Segmental Revenue Shares, 2021
10.10.4.3 Regional Revenue Shares, 2021
10.10.5 Recent Developments, 2020
10.11 SAMSUNG BIOLOGICS
10.11.1 Company Overview
10.11.2 Company Snapshot
10.11.3 Service Portfolio
10.11.4 Financial Analysis
10.11.4.1 Segmental Revenue Shares, 2020
10.11.4.2 Regional Revenue Shares, 2020
10.11.5 Recent Developments, 2017-2020
10.12 WUXI APPTEC (WUXI STA)
10.12.1 Company Overview
10.12.2 Company Snapshot
10.12.3 Service Portfolio
10.12.4 Recent Developments, 2018-2020
10.13 FUJIFILM HEALTHCARE
10.13.1 Company Overview
10.13.2 Company Snapshot
10.13.3 Service Portfolio
10.13.4 Financial Analysis
10.13.4.1 Net Revenue, 2016-2019
10.13.4.2 Segmental Revenue Shares, 2019
10.13.4.3 Regional Revenue Shares, 2019
10.13.5 Recent Developments, 2017-2018
10.14 ICON PLC
10.14.1 Company Overview
10.14.2 Company Snapshot
10.14.3 Service Portfolio
10.15 ABNOVA CORPORATION
10.15.1 Company Overview
10.15.2 Company Snapshot
10.15.3 Service Portfolio
10.16 VETTER PHARMA INTERNATIONAL
10.16.1 Company Overview
10.16.2 Company Snapshot
10.16.3 Service Portfolio
11 Conclusion and Recommendations
11.1 Concluding Remarks from Visiongain
11.2 Recommendations for Market Players
11.3 Leading and Fastest Growing Region
List of Tables
Table 1 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 2 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 3 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 4 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 6 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 7 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 8 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 9 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 10 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 11 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 12 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 13 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 14 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 15 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 16 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 17 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 18 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 19 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 20 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 21 Global Pharmaceutical Contract Manufacturing Market Forecast For Parenteral/injectable manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 22 Global Pharmaceutical Contract Manufacturing Market Forecast For Tablet manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 23 Global Pharmaceutical Contract Manufacturing Market Forecast For Capsule manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 24 Global Pharmaceutical Contract Manufacturing Market Forecast For Oral liquid manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 25 Global Pharmaceutical Contract Manufacturing Market Forecast For Semi-solid manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 26 Global Pharmaceutical Contract Manufacturing Market Forecast For Other Formulation manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 27 Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 28 Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 29 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 30 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug
Figure 44. Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 31 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 32 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 33 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 34 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 35 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 36 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 37 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 38 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 39 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 40 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 41 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 42 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 43 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%) : V-Shaped Recovery
Table 44 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 45 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 46 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 47 Global Pharmaceutical Contract Manufacturing Market Forecast by End User, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 48 Global Pharmaceutical Contract Manufacturing Market Forecast For Big Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 49 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies (PCR), 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 50 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 51 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 52 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 53 Global Pharmaceutical Contract Manufacturing Market Forecast For Small & Medium-Sized Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 54 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 55 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 56 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 57 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 58 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 59 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 60 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies (ISH), 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 61 Global Pharmaceutical Contract Manufacturing Market Forecast for Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 62 Global Pharmaceutical Contract Manufacturing Market Forecast for Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 63 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 64 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 65 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 66 Global Pharmaceutical Contract Manufacturing Market Forecast for Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 67 Global Pharmaceutical Contract Manufacturing Market Forecast for Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 68 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
Table 69 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 70 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 71 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 72 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 73 North America Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 74 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 75 North America Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 76 North America Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 77 North America Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 78 US Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 79 US Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 80 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 81 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 82 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 83 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 84 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 85 Canada Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 86 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 87 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 88 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 89 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 90 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 92 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 93 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 94 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
Table 95 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 96 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 97 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 98 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 99 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 100 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 101 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 102 Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 103 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 104 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 105 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 106 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 107 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 108 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 109 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 110 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 111 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 112 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 113 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 114 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 115 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 116 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 117 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 118 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 119 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 120 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 121 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 122 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 123 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 124 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 125 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 126 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 127 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 128 France Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 129 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 130 France Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 131 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 132 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 133 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 134 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 135 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 136 Italy Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 137 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 138 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 139 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 140 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 141 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 142 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 143 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 144 Spain Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 145 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 146 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 147 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 148 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 149 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 150 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 151 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 152 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 153 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 154 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 155 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 156 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 157 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 158 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 159 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 160 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
Table 161 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 162 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 163 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 164 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 165 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 166 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 167 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 168 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 169 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 170 Japan Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 171 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 172 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 173 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 174 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 175 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 176 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 177 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 178 China Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 179 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 180 China Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 181 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 182 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 183 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 184 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 185 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 186 India Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 187 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 188 India Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 189 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 190 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 191 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 192 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 193 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 194 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 195 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 196 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 197 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 198 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 199 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 200 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 201 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 202 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 203 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 204 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 205 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 206 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 207 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 208 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 209 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 209 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
Table 210 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 211 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 212 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 213 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 214 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 215 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 216 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 217 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 218 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 219 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 220 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 221 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 222 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 223 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 224 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 225 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 226 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 227 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 229 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 230 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 231 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 232 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 233 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 234 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 235 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 236 Saudi Arabia Pharmaceutical Contract Manufacturing Market Value by Service, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 237 Saudi Arabia Pharmaceutical Contract Manufacturing Market Value by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 238 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 239 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 240 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 241 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 242 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 243 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 244 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 245 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 246 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 247 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 248 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 249 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 250 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 251 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
List of Figures
Figure 1 Global Pharmaceutical Contract Manufacturing Market Segmentation
Figure 2 Global Pharmaceutical Contract Manufacturing Market: Market Trends
Figure 3 Global Pharmaceutical Contract manufacturing Market: SWOT Analysis
Figure 4 Pharmaceutical Contract Manufacturing Market Porter’s Five Forces.
Figure 5 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: V-Shaped Recovery
Figure 6 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: U-Shaped Recovery
Figure 7 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: L-Shaped Recovery
Figure 8 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: W-Shaped Recovery
Figure 9 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
Figure 9. Global Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2021, 2027, 2032 (%)
Figure 10. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical Manufacturing Services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
Figure 11. Global Pharmaceutical Contract Manufacturing Market Share for Pharmaceutical Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 12. Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 13. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 14. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 15. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 16. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical API Manufacturing Services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 17. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical API Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 18. Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 19. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 20. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 21. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 22. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical FDF Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 23. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical FDF Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 24. Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 25. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services (USD Billion), 2022-2032: U-Shaped Recovery
Figure 26. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 27. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 28. Global Pharmaceutical Contract Manufacturing Market Share For Parenteral/injectable manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 29. Global Pharmaceutical Contract Manufacturing Market Share For Parenteral/injectable manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 30. Global Pharmaceutical Contract Manufacturing Market Share For Tablet manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 31. Global Pharmaceutical Contract Manufacturing Market Share For Tablet manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 32. Global Pharmaceutical Contract Manufacturing Market Share For Capsule manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 33. Global Pharmaceutical Contract Manufacturing Market Share For Capsule manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 34. Global Pharmaceutical Contract Manufacturing Market Share For Oral liquid manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 35. Global Pharmaceutical Contract Manufacturing Market Share For Oral liquid manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 36. Global Pharmaceutical Contract Manufacturing Market Share For Semi-solid manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 37. Global Pharmaceutical Contract Manufacturing Market Share For Semi-solid manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 38. Global Pharmaceutical Contract Manufacturing Market Share For Other Formulation manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 39. Global Pharmaceutical Contract Manufacturing Market Share For Other Formulation manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 40. Global Pharmaceutical Contract Manufacturing Market Share For Drug Development Services, Forecast by Region 2022-2032 (US$ billion, AGR %)
Figure 41. Global Pharmaceutical Contract Manufacturing Market Share For Drug Development Services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 42. Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 43. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 45. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 46. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 47. Global Pharmaceutical Contract Manufacturing Market Share For Biologics contract manufacturing services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
Figure 48. Global Pharmaceutical Contract Manufacturing Market Share For Biologics contract manufacturing services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 49. Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 50. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 51. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 52. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 53. Global Pharmaceutical Contract Manufacturing Market Share For Biologics API Manufacturing Services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
Figure 54. Global Pharmaceutical Contract Manufacturing Market Share For Biologics API Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 55. Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 56. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 57. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 58. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 59. Global Pharmaceutical Contract Manufacturing Market Share For Biologics FDF Manufacture Service, Forecast by Region, 2022-2032 (US$ billion, AGR %)
Figure 60. Global Pharmaceutical Contract Manufacturing Market Share For Biologics FDF Manufacture Service, Forecast by Region, 2021, 2027, 2032 (%)
Figure 61. Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 62. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 63. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 64. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 65. Global Pharmaceutical Contract Manufacturing Market, Forecast by End User, 2022-2032 (US$ billion, AGR %)
Figure 66.
Figure 67. Global Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 68. Global Pharmaceutical Contract Manufacturing Market Share For Big Pharmaceutical Companies, Forecast by Region, 2022-2032 (US$ billion, AGR %)
Figure 69. Global Pharmaceutical Contract Manufacturing Market Share Forecast For Big Pharmaceutical Companies by Region, 2021, 2027, 2032 (%)
Figure 70. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 71. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 72. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 73. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 74. Global Pharmaceutical Contract Manufacturing Market Share For Small & Medium-Sized Pharmaceutical Companies, Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 75. Global Pharmaceutical Contract Manufacturing Market Share Forecast For Small & Medium-Sized Pharmaceutical Companies by Region, 2021, 2027, 2032 (%)
Figure 76. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 77. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Small & Medium-Sized Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 78. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 79. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 80. Global Pharmaceutical Contract Manufacturing Market Share For Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 81. Global Pharmaceutical Contract Manufacturing Market Share Forecast For Generic Pharmaceutical Companies by Region, 2021, 2027, 2032 (%)
Figure 82. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Generic Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 83. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Generic Pharmaceutical Companies (ISH) 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 84. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Generic Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 85. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Generic Pharmaceutical Companies 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 86. Global Pharmaceutical Contract Manufacturing Market Share For Other End Users by Region, 2021- 2031 (US$ Billion)
Figure 87. Global Pharmaceutical Contract Manufacturing Market Share Forecast For Other End Users by Region, 2021, 2027, 2032 (%)
Figure 88. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Other End Users 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 89. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market For Other End Users 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 90. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Other End Users 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 91. COVID-19 Impact on Pharmaceutical Contract Manufacturing Market for Other End Users 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 93 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 94 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 95 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 96 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 97 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 92. North America Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 98 North America Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2021, 2021 and 2032 (%)
Figure 93. North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 99 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 94. North America Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 100 North America Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 95. North America Pharmaceutical Contract Manufacturing Market Share Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 101 North America Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 96. North America Pharmaceutical Contract Manufacturing Market Share Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 102 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2021, 2027, 2032 (%)
Figure 97. US Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 103 US Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 104 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 105 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 106 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 107 US Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 108 US Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 109 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 110 US Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 111 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%) : V-Shaped Recovery
Figure 112 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 113 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 114 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 115 Canada Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 116 Canada Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 117 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 118 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 119 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 120 Canada Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 121 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 122 Canada Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 123 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR %) V-Shaped Recovery
Figure 124 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 125 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 126 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 127 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 128 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 129 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 130 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 131 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 132 Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by Products & Services, 2022-2032 (US$ billion, AGR%, CAGR%)
Figure 133 Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2021, 2027 and 2032 (%)
Figure 134 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 135 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 136 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 137 Europe Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 138 Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 139 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 140 Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 141 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2021, 2027, 2032 (%)
Figure 142 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 143 Germany Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 144 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 145 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 146 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 147 Germany Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 148 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 149 Germany Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 150 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 151 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 152 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 153 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 154 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 155 UK Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 156 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 157 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 158 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 159 UK Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 160 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 161 UK Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 162 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 163 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 164 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 165 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 166 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 167 Switzerland Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 168 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 169 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 170 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 171 Switzerland Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 172 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 173 Switzerland Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 174 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 175 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 176 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 177 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market (USD Billion, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 178 France Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 179 France Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 180 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 181 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 182 France Biologics Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 183 France Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 184 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 185 France Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 186 COVID-19 Impact on France Pharmaceutical Contract Manufacturing 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 187 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 188 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 189 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market (USD Billion,2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 190 Italy Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 191 Italy Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 192 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 193 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 194 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 195 Italy Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 196 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 197 Italy Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 198 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 200 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 201 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 202 Spain Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 203 Spain Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 204 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 205 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 206 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 207 Spain Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 208 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 209 Spain Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 210 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 211 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 212 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 213 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 214 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 215 Rest of Europe Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 216 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 217 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 218 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 219 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 220 Rest of Europe Biologics Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 221 Rest of Europe Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 222 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 223 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 224 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 225 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 226 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 227 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market (USD Billion), 2019-2031: V-Shaped Recovery
Figure 228 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: U-Shaped Recovery
Figure 229 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: L-Shaped Recovery
Figure 230 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: W-Shaped Recovery
Figure 98. Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 231 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2021, 2027 and 2032 (%)
Figure 99. Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 232 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 233 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 234 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 235 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 236 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 237 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 238 Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2021, 2027, 2032 (%)
Figure 239 Japan Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 240 Japan Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 241 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 242 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 243 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 244 Japan Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 245 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 246 Japan Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 247 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 248 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 249 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 250 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%)W-Shaped Recovery
Figure 251 China Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 252 China Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 253 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 254 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 255 China Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 256 China Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 257 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 258 China Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 259 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 260 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 261 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 262 COVID-19 Impact on China Pharmaceutical Contract Manufacturing 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 263 India Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 264 India Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 265 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 266 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 267 India Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 268 India Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 269 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 270 India Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 271 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 272 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 273 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market, 2022-2032 (US$ billion, AGR%, CAGR%) 2022-2032: L-Shaped Recovery
Figure 274 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 275 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 276 South Korea Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 277 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 278 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 279 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 280 South Korea Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 281 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 282 South Korea Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 283 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 284 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 286 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 287 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 288 Rest of APAC Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 289 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 290 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 291 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 292 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 293 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 294 Rest of APAC Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 295 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 296 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 297 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 298 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 299 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 300 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 301 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 302 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 303 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 304 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 305 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by Product& Services, 2021, 2027 and 2032 (%)
Figure 306 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 307 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 308 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 309 LAMEA Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 310 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 311 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 312 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 313 LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2021, 2027, 2032 (%)
Figure 314 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 315 Brazil Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 316 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 317 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 318 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 319 Brazil Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 320 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 321 Brazil Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 322 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 323 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR %) U-Shaped Recovery
Figure 324 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 325 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 326 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 327 Mexico Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 328 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 329 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 330 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 331 Mexico Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 332 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 333 Mexico Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 334 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 335 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 336 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 337 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 338 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Services, 2021- 2031 (US$ Billion)
Figure 339 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 340 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021- 2031 (US$ Billion)
Figure 341 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 342 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2021- 2032 (US$ Billion)
Figure 343 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 344 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast by End User,, 2021- 2032 (US$ Billion)
Figure 345 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 346 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market (USD Billion), 2019-2031: V-Shaped Recovery
Figure 347 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 348 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 349 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 350 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 351 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast, by Services, 2021, 2027, 2032 (%)
Figure 352 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 353 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 354 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 355 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2021, 2027, 2032 (%)
Figure 356 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Figure 357 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2021, 2027, 2032 (%)
Figure 358 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Figure 359 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Figure 360 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Figure 361 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market , 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Figure 363 Lonza: Net Revenue, 2016-2020 (US$ Million, AGR%)
Figure 364 Lonza: Segmental Revenue Shares 2020
Figure 365 Lonza: Regional Revenue Shares 2020
Figure 366 THERMO FISHER SCIENTIFIC: Net Revenue, 2017-2020 (US$ Million, AGR %)
Figure 367 THERMO FISHER SCIENTIFIC: Segmental Revenue Shares 2020
Figure 368 Thermo Fisher Scientific: Regional Revenue Shares 2020
Figure 369 CATALENT: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 370 CATALENT: Segmental Revenue Shares 2021
Figure 371 CATALENT: Regional Revenue Shares 2021
Figure 372 RECIPHARM AB: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 373 RECIPHARM AB: Segmental Revenue Shares 2020
Figure 374 ABBVIE: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 375 ABBVIE: Segmental Revenue Shares 2020
Figure 376 ABBVIE: Regional Revenue Shares 2020
Figure 377 SIEGFRIED: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 378 Evonik: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 379 Evonik: Segmental Revenue Shares 2020
Figure 380 Evonik: Regional Revenue Shares 2019
Figure 381 Boehringer Ingelheim: Net Revenue, 2016-2020 (US$ Million, AGR %)
Figure 382 Boehringer Ingelheim: Segmental Revenue Shares 2020
Figure 383 Boehringer Ingelheim: Regional Revenue Shares 2020
Figure 384 Piramal Enterprises: Net Revenue, 2017-2021 (US$ Million, AGR %)
Figure 385 Primal Enterprises: Segmental Revenue Shares 2021
Figure 386 Primal Enterprises: Regional Revenue Shares 2021
Figure 387 Samsung Biologics: Segmental Revenue Shares 2020
Figure 388 Samsung Biologics: Regional Revenue Shares 2020
Figure 389 Fujifilm: Net Revenue, 2016-2019 (US$ Million, AGR %)
Figure 390 Fujifilm: Segmental Revenue Shares 2019
Figure 391 Fujifilm: Regional Revenue Shares 2019
Figure 392 Pharmaceutical Contract Manufacturing Market Share Forecast, by Region, 2021, 2027 and 2032 (%)
AbbVie Inc.
Abnova Corporation
Boehringer Ingelheim International GmbH
Catalent, Inc.
Evonik Industries AG
Fujifilm Corporation
ICON PLC
Lonza Group Ltd.
Piramal Pharma Solutions
Recipharm AB
Samsung Biologics
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Vetter Pharma International GmbH
WuXiAppTec
List of Other Companies
Actavis
ADC Biotechnology
Aegerion Pharmaceuticals
Aesica Pharma
Alexion Pharmaceuticals
Astellas
Boehringer Ingelheim
Bristol-Myers Squibb Company
Daito Pharmaceutical
Delpharm
DPx Holdings B.V.
Dr. Reddy's Laboratories
Eisai
Eli Lilly
G-CON
Gallus Biopharmaceutical, LLC.
GlaxoSmithKline (GSK)
Indian Pharmaceutical Alliance
Innovent Biologics
IRIX Pharmaceuticals
Janssen
JK Pharmaceutical
Johnson & Johnson
Lupin
Marinopoulos Group
Matrix Laboratories
Medice
Medichem
Merck & Co.
Mylan
Neuland Laboratories
Orchid Chemicals & Pharmaceuticals
Oxford Biomedica
Progenics
Recepta Biopharma
Roche
Shire
SMS Pharmaceuticals
Takeda
Valeant Pharmaceuticals
West Pharmaceutical Services
List of Organizations
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
European Commission
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
Indian Drug Manufacturer's Association (IDMA)
International Society of Pharmaceutical Engineering (IPSE)
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer's Association (KPMA)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
Pharmaceutical and Medical Devices Agency (PMDA)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Pharmaceutical Contract Manufacturing Market Report 2022-2032
Related reports
-
Vaccine Delivery Devices Market Report 2021-2031
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product...Full DetailsPublished: 06 January 2021 -
Pharma Wholesale and Distribution Market Report 2022-2032
The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a...Full DetailsPublished: 29 September 2022 -
Contract Research Organisations (CROs) Market Report 2022-2032
The global Contract Research Organizations (CROs) market was valued at US$57.1 billion in 2021 and is projected to grow at...Full DetailsPublished: 12 August 2022 -
Fill-Finish Manufacturing Market Report 2023-2033
The global Fill-Finish Manufacturing market is projected to grow at a CAGR of 9.2% by 2033...Full DetailsPublished: 10 February 2023 -
Vaccine Sales Market Report 2022-2032
Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for...Full DetailsPublished: 21 April 2022 -
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2022-2032
The global CMO of Sterile Injectable Drugs market is projected to grow at a CAGR of 9.10% by 2032....Full DetailsPublished: 16 December 2022 -
Decentralized Clinical Trials Market Report 2022-2032
Some of the factors driving the market growth are the rising geriatric population, increasing prevalence of cancer, and rising demand...Full DetailsPublished: 24 January 2022 -
Biopharmaceuticals Contract Manufacturing Market Report 2023-2033
The global Biopharmaceuticals Contract Manufacturing market is projected to grow at a CAGR of 10% by 2033...Full DetailsPublished: 03 April 2023 -
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031
Contract manufacturing outsourcing is gaining attraction owing to growing trend of outsourcing among pharmaceutical businesses. ...Full DetailsPublished: 16 November 2021 -
Veterinary Vaccines Market Report 2022-2032
The increased frequency of zoonotic illnesses, activities by different government agencies and animal groups to protect animal health, and the...Full DetailsPublished: 28 February 2022
Download sample pages
Complete the form below to download your free sample pages for Pharmaceutical Contract Manufacturing Market Report 2022-2032
Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Latest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024